Analyze Diet

Topic:Glucosamine

Glucosamine is a naturally occurring compound that is often used in horses to support joint health. It is a component of glycosaminoglycans, which are integral to the formation and repair of cartilage. In equine applications, glucosamine is commonly administered as a dietary supplement with the intent of maintaining joint function and mobility. Research studies have explored its pharmacokinetics, bioavailability, and potential effects on joint tissues in horses. This page provides access to peer-reviewed research and scholarly articles that investigate the use, efficacy, and physiological impact of glucosamine supplementation in equine joint health management.
Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses.
BMC veterinary research    June 9, 2022   Volume 18, Issue 1 215 doi: 10.1186/s12917-022-03323-3
Yamada ALM, do Prado Vendruscolo C, Marsiglia MF, Sotelo EDP, Agreste FR, Seidel SRT, Fülber J, Baccarin RYA, da Silva LCLC.Combined chondroitin sulfate (CS) and glucosamine (GlcN) has been widely used in oral formulations to prevent and treat osteoarthritis. CS is effective for controlling pain in osteoarthritic patients, whereas GlcN can stimulate glycosaminoglycan synthesis, thus reducing extracellular matrix degradation. Although several studies have been published on this topic, the effectiveness of treatment with oral CS and GlcN remains uncertain. The objective of this study was to analyze the progression of experimentally induced osteoarthritis in horses and verify the effectiveness of an oral compound base...
Undenatured Type II Collagen (UC-II) in Joint Health and Disease: A Review on the Current Knowledge of Companion Animals.
Animals : an open access journal from MDPI    April 17, 2020   Volume 10, Issue 4 doi: 10.3390/ani10040697
Gencoglu H, Orhan C, Sahin E, Sahin K.OA is quite common in companion animals, especially in large breed dogs and horses. Collagen, the most abundant protein of mammals, has specific connective tissue types for skin, bones, reticulate, basal lamina, bones, cell surfaces, while type II collagen (UC-II) forms the main structure of cartilage tissue. Even at the smaller dosages, UC-II has also been reported to be more effective than the glucosamine and chondroitin sulfate supplements, which are the supplements most frequently used in the market. In this review, we summarize the effects of UC-II on joint health and function in health a...
Avocado/Soybean Unsaponifiables, Glucosamine and Chondroitin Sulfate Combination Inhibits Proinflammatory COX-2 Expression and Prostaglandin E2 Production in Tendon-Derived Cells.
Journal of medicinal food    September 5, 2019   Volume 23, Issue 2 139-146 doi: 10.1089/jmf.2019.0022
Grzanna MW, Au RY, Au AY, Rashmir AM, Frondoza CG.Tendinopathy, a common disorder in man and horses, is characterized by pain, dysfunction, and tendon degeneration. Inflammation plays a key role in the pathogenesis of tendinopathy. Tendon cells produce proinflammatory molecules that induce pain and tissue deterioration. Currently used nonsteroidal anti-inflammatory drugs are palliative but have been associated with adverse side effects prompting the search for safe, alternative compounds. This study determined whether tendon-derived cells' expression of proinflammatory cyclooxygenase (COX)-2 and production of prostaglandin E2 (PGE) could be a...
Influence of oral glucosamine supplementation in young horses challenged with intra-articular lipopolysaccharide.
Journal of animal science    October 4, 2016   Volume 94, Issue 8 3294-3302 doi: 10.2527/jas.2016-0343
Leatherwood JL, Gehl KL, Coverdale JA, Arnold CE, Dabareiner RA, Walter KN, Lamprecht ED.Fourteen yearling Quarter horses (351 to 470 kg) were utilized in a randomized complete block design to evaluate potential of glucosamine hydrochloride (HCl) to mitigate intra-articular inflammation following a single inflammatory insult. Horses were blocked by BW, age, and sex, and randomly assigned to treatments for a 98-d experiment. Treatments consisted of a control diet (CON; = 7) fed 1% BW per d (as-fed) of concentrate only or a treatment diet ( = 7) of concentrate top dressed with 30 mg/kg BW glucosamine HCl (99.6% purity; GLU30) offered at 12 h intervals. Horses were maintained in indi...
Urinary glycosaminoglycans in horse osteoarthritis. Effects of chondroitin sulfate and glucosamine.
Research in veterinary science    September 16, 2011   Volume 93, Issue 1 88-96 doi: 10.1016/j.rvsc.2011.08.009
Baccarin RY, Machado TS, Lopes-Moraes AP, Vieira FA, Michelacci YM.Our objectives were to characterize the urinary excretion of glycosaminoglycans (GAGs) in horse osteoarthritis, and to investigate the effects of chondroitin sulfate (CS) and glucosamine (GlcN) upon the disease. Urinary GAGs were measured in 47 athletic horses, 20 healthy and 27 with osteoarthritis. The effects of CS and GlcN were investigated in mild osteoarthritis. In comparison to normal, urinary GAGs were increased in osteoarthritis, including mild osteoarthritis affecting only one joint. Treatment with CS+GlcN led to a long lasting increase in the urinary CS and keratan sulfate (KS), and ...
Low quality of evidence for glucosamine-based nutraceuticals in equine joint disease: review of in vivo studies.
Equine veterinary journal    November 26, 2009   Volume 41, Issue 7 706-712 doi: 10.2746/042516409x424153
Pearson W, Lindinger M.Nutraceuticals are increasingly applied to the management of equine arthritis and joint disease, particularly those based upon glucosamine and chondroitin sulphate. While the first report of using glucosamine in horses appeared more than 25 years ago, it was not until 1992 that isolated studies began to be reported. Since that time, 15 in vivo papers have been published in the equine literature, usually on products already commercially available and often seeking evidence for efficacy. These studies demonstrate an encouraging trend to manufacturers of these products investing in research, but ...
Effects of methylprednisolone acetate and glucosamine on proteoglycan production by equine chondrocytes in vitro.
American journal of veterinary research    September 4, 2008   Volume 69, Issue 9 1123-1128 doi: 10.2460/ajvr.69.9.1123
Byron CR, Benson BM, Stewart AA, Pondenis HC.To evaluate the effects of methylprednisolone acetate (MPA) on proteoglycan production by equine chondrocytes and to investigate whether glucosamine hydrochloride modulates these effects at clinically relevant concentrations. Methods: Articular cartilage with normal gross appearance from metacarpophalangeal and metatarsophalangeal joints of 8 horses (1 to 10 years of age). Methods: In vitro chondrocyte pellets were pretreated with glucosamine (0, 1, 10, and 100 microg/mL) for 48 hours and exposed to MPA (0, 0.05, and 0.5 mg/mL) for 24 hours. Pellets and media were assayed for proteoglycan prod...
Effects of clinically relevant concentrations of glucosamine on equine chondrocytes and synoviocytes in vitro.
American journal of veterinary research    September 4, 2008   Volume 69, Issue 9 1129-1134 doi: 10.2460/ajvr.69.9.1129
Byron CR, Stewart MC, Stewart AA, Pondenis HC.To evaluate the effects of glucosamine on equine articular chondrocytes and synoviocytes at concentrations clinically relevant to serum and synovial fluid concentrations. Methods: Articular cartilage and synovium with normal gross appearance from metacarpophalangeal and metatarsophalangeal joints of 8 horses (1 to 10 years of age). Methods: In vitro chondrocyte and synoviocyte cell cultures from 8 horses were treated with glucosamine (0.1 to 20 microg/mL) with or without interleukin-1 (IL-1; 10 ng/mL) for 48 hours. Negative control cultures received no glucosamine or IL-1, and positive control...
Joint inflammation increases glucosamine levels attained in synovial fluid following oral administration of glucosamine hydrochloride.
Osteoarthritis and cartilage    August 8, 2008   Volume 17, Issue 2 228-234 doi: 10.1016/j.joca.2008.06.018
Meulyzer M, Vachon P, Beaudry F, Vinardell T, Richard H, Beauchamp G, Laverty S.To compare synovial glucosamine levels in normal and inflamed equine joints following oral glucosamine administration and to determine whether single dose administration alters standard synovial parameters of inflammation. Methods: Eight adult horses were studied. On weeks 1 and 2, all horses received 20mg/kg glucosamine hydrochloride by nasogastric (NG) intubation or intravenous injection. On weeks 3 and 4, 12h after injection of both radiocarpal joints with 0.25 ng Escherichia coli lipopolysaccharide (LPS) to induce inflammation, glucosamine hydrochloride or a placebo was administered by NG ...
Medical treatment of osteoarthritis in the horse – a review.
Veterinary journal (London, England : 1997)    January 24, 2006   Volume 171, Issue 1 51-69 doi: 10.1016/j.tvjl.2004.07.008
Goodrich LR, Nixon AJ.The medical treatment of osteoarthritis (OA) in the horse is one of the most utilized therapeutic regimens in the equine practice. It is important to understand the anatomy of synovial joints and the pathophysiology of the disease process to treat OA adequately. Once a thorough understanding of the disease process is comprehended the proper combination of systemic nonsteroidal anti-inflammatory drugs (NSAIDs), intraarticular steroids, viscosupplementation and chondroprotectants can be used to treat the disease and inhibit further progression of degenerative changes to the cartilage surface. Th...
Effects of glucosamine and chondroitin sulfate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta.
American journal of veterinary research    December 13, 2005   Volume 66, Issue 11 1861-1869 doi: 10.2460/ajvr.2005.66.1861
Neil KM, Orth MW, Coussens PM, Chan PS, Caron JP.To determine whether glucosamine and chondroitin sulfate (CS) at concentrations approximating those achieved in plasma by oral administration would influence gene expression of selected mediators of osteoarthritis in cytokine-stimulated equine articular chondrocytes. Methods: Samples of grossly normal articular cartilage obtained from the metacarpophalangeal joint of 13 horses. Methods: Equine chondrocytes in pellet culture were stimulated with a subsaturating dose of recombinant equine interleukin (reIL)-1beta. Effects of prior incubation with glucosamine (2.5 to 10.0 microg/mL) and CS (5.0 t...
Skeptical of treatment with glucosamine and chondroitin sulfate.
Journal of the American Veterinary Medical Association    June 7, 2005   Volume 226, Issue 11 1798-1800 doi: 10.2460/javma.2005.226.1798
Ramey DW.No abstract available
The role of glucosamine and chondroitin sulfate in treatment for and prevention of osteoarthritis in animals.
Journal of the American Veterinary Medical Association    April 14, 2005   Volume 226, Issue 7 1079-1088 doi: 10.2460/javma.2005.226.1079
Neil KM, Caron JP, Orth MW.No abstract available
Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses.
Arthritis and rheumatism    January 11, 2005   Volume 52, Issue 1 181-191 doi: 10.1002/art.20762
Laverty S, Sandy JD, Celeste C, Vachon P, Marier JF, Plaas AH.To examine the concentration of glucosamine in the synovial fluid and its pharmacokinetics in serum in a large animal model following dosing with glucosamine HCl at clinically relevant levels. Methods: Eight adult female horses were studied. After an overnight fast, glucosamine HCl (20 mg/kg of body weight) was administered by either nasogastric (NG) intubation or intravenous (IV) injection. Blood samples were collected before dosing and at 5, 15, 30, 60, 120, 180, 240, 360, 480, and 720 minutes after dosing. Synovial fluid samples were collected from the radiocarpal joints 48 hours before dos...
The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse.
Biopharmaceutics & drug disposition    April 15, 2004   Volume 25, Issue 3 109-116 doi: 10.1002/bdd.392
Du J, White N, Eddington ND.The purpose of this study was to determine if glucosamine (GL) hydrochloride (FCHG49) and low molecular weight (LMW) chondroitin sulfate (CS) (TRH122) are absorbed after oral administration to horses. The bioavailability of LMWCS was evaluated by quantifying the total disaccharides found in the plasma following chondroitinase ABC digestion. Methods: Two separate studies were conducted. In study 1, ten adult horses received the following four treatments in a randomized crossover fashion: (1) i.v. LMWCS (3 g of 8 kDa), (2) p.o. LMWCS (3 g of 8 kDa), (3) i.v. LMWCS (3 g of 16.9 kDa) and (4) p.o. ...
Effect of glucosamine on interleukin-1-conditioned articular cartilage.
Equine veterinary journal. Supplement    October 31, 2002   Issue 34 219-223 doi: 10.1111/j.2042-3306.2002.tb05422.x
Fenton JI, Chlebek-Brown KA, Caron JP, Orth MW.Glucosamine inhibits recombinant human interleukin-1 stimulated cartilage degradation in equine cartilage explants. Recently, recombinant equine interleukin-1 has been cloned and purified. Therefore, the objective of this study was to characterise the effects of glucosamine on indices of cartilage degradation in recombinant equine IL-1beta-stimulated equine articular cartilage explants. Cartilage discs were harvested from the weight-bearing region of the articular surface of the antebrachiocarpal and middle carpal joints of horses (age 2-8 years) and cultured under standard conditions. Explant...
Serum concentrations of keratan sulfate, osteocalcin, and pyridinoline crosslinks after oral administration of glucosamine to standardbred horses during race training.
American journal of veterinary research    August 13, 2002   Volume 63, Issue 8 1106-1110 doi: 10.2460/ajvr.2002.63.1106
Caron JP, Peters TL, Hauptman JG, Eberhart SW, Orth MW.To determine the effects of orally administered glucosamine on concentrations of markers of bone and cartilage metabolism in Standardbred horses during race training. Methods: Twenty 16- to 20-month-old Standardbreds beginning race training. Methods: Horses were randomly assigned to 2 groups. One group received glucosamine hydrochloride (4 g, PO, q 12 h), and the second (control) group received glucose (4 g, PO, q 12 h). Serum samples were obtained prior to onset of the study (baseline) and at regular intervals for 48 weeks for determination of concentrations of keratan sulfate (KS), osteocalc...
The effects of glucosamine derivatives on equine articular cartilage degradation in explant culture.
Osteoarthritis and cartilage    November 9, 2000   Volume 8, Issue 6 444-451 doi: 10.1053/joca.1999.0320
Fenton JI, Chlebek-Brown KA, Peters TL, Caron JP, Orth MW.To determine whether glucosamine-3-sulfate, glucose-3-sulfate (control) and N-acetyl glucosamine inhibit experimentally induced degradation of equine articular cartilage explants similar to glucosamine HCl. Methods: Articular cartilage was obtained from the antebrachio-carpal and middle joints of horses (2-8 years old) killed for reasons unrelated to lameness. Cartilage discs were harvested from the weight-bearing region of the articular surface and cultured. Media were exchanged daily and the recovered media stored at 4 degrees C. On days 1 and 2 lipopolysaccharide (LPS, 10 microg/ml) was add...
Glucosamine HCl reduces equine articular cartilage degradation in explant culture.
Osteoarthritis and cartilage    July 25, 2000   Volume 8, Issue 4 258-265 doi: 10.1053/joca.1999.0299
Fenton JI, Chlebek-Brown KA, Peters TL, Caron JP, Orth MW.Objective To determine whether glucosamine inhibits experimentally induced degradation of equine articular cartilage explants. Methods Articular cartilage was obtained from the antebrachio-carpal and middle joints of horses (2-8 years old) killed for reasons unrelated to lameness. Cartilage discs were harvested from the weight-bearing region of the articular surface and cultured. Media were exchanged daily and the recovered media stored at 4 degrees C. Explants were maintained in basal media 2 days prior to the start of four treatment days. On days 1-4 lipopolysaccharide (LPS, 10 microg/ml) or...
Effect of longeing and glucosamine supplementation on serum markers of bone and joint metabolism in yearling quarter horses.
Canadian journal of veterinary research = Revue canadienne de recherche veterinaire    October 26, 1999   Volume 63, Issue 4 288-291 
Fenton JI, Orth MW, Chlebek-Brown KA, Nielsen BD, Corn CD, Waite KS, Caron JP.The effect of longeing and glucosamine supplementation on known biological markers of joint disease was studied in yearling quarter horses. Twenty-one yearling quarter horses were randomly assigned to one of 4 treatments: 1) longeing (longeing 20 min daily) supplement control (LN); 2) longeing/glucosamine (LG); 3) walking (mechanical walker for 120 min daily (WN)); and 4) walking/glucosamine (WG). Oral glucosamine was administered at 5.5 g b.i.d. weeks 1-4, 3.5 g b.i.d. during weeks 5-6, and 2.0 g b.i.d. during weeks 7-8. Serum was obtained weekly for 8 wk and analyzed for keratan sulfate and ...
Morphologic and biochemical study of sternal cartilage autografts for resurfacing induced osteochondral defects in horses.
American journal of veterinary research    June 1, 1992   Volume 53, Issue 6 1038-1047 
Vachon AM, McIlwraith CW, Powers BE, McFadden PR, Amiel D.Using biodegradable pins, sternal cartilage autografts were fixed into osteochondral defects of the distal radial carpal bone in ten 2 to 3-year-old horses. The defects measured 1 cm2 at the surface and were 4 mm deep. Control osteochondral defects of contralateral carpi were not grafted. After confinement for 7 weeks, horses were walked 1 hour daily on a walker for an additional 9 weeks. Horses were euthanatized at 16 weeks. Half of the repair tissue was processed for histologic and histochemical (H&E and safranin-O fast green) examinations. The other half was used for the following bioch...
[Causal treatment of arthrosis deformans in horses with glucosaminsulfate].
DTW. Deutsche tierarztliche Wochenschrift    July 6, 1982   Volume 89, Issue 7 288-293 
Jaeschke G, Steinbach W.No abstract available